Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Biobank scale pharmacogenomics informs the genetic underpinnings of simvastatin use

10.1101/2020.11.23.20235846Source: DataRank Database

Biobank scale pharmacogenomics informs the genetic underpinnings of simvastatin use is a research paper. On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: greenTopics (20)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Dora Koller,Gita A Pathak,Daniel Jacoby ORCID,Edward J Miller,Renato Polimanti ORCID

Live enrichment

PubMed:33837531

National Institutes of Health

Grant: 1R21DA047527-01

Investigating the Systems Genetics of the Patterns of Polysubstance Abuse and Addiction

National Institutes of Health

Grant: 5R21DC018098-03

Genome-wide Investigation of the Interplay Between Age-Related Hearing Loss and Smoking Behaviors

greenLicense: other-oa

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2020/11/24/2020.11.23.20235846.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2020.11.23.20235846

https://doi.org/10.1002/cpt.2260

https://doi.org/10.1101/2020.11.23.20235846

https://pubmed.ncbi.nlm.nih.gov/33837531

Fields of Study

0301 basic medicine03 medical and health sciences

Keywords

AdultMaleSimvastatinGenotypeArylamine N-AcetyltransferasePilot ProjectsCholesterol, LDLMiddle AgedCohort StudiesPhenotypeHaplotypesPharmacogeneticsInactivation, MetabolicOdds RatioHumansFemaleAgedBiological Specimen Banks

Sustainable Development Goals

SDG 3: 3. Good health

Biobank scale pharmacogenomics informs the genetic underpinnings of simvastatin use

FAIR Checklist

Authors (6)

Funding (2 grants)

Open Access

Topics